Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The newly identified tumor suppressor,
N-myc downstream-regulated gene 2
(
NDRG2
), has been studied in various cancers because of its anticancer and antimetastasis effects. In this study, we examined the effect of
NDRG2
expression on cell viability in MDA-MB-231 human breast cancer cells under conditions that are similar to the microenvironment of solid tumors, which include glucose deprivation.
NDRG2
overexpression enhanced the pro-apoptotic effects of glucose deprivation. Glucose deprivation also induced the activation of AMP-activated protein kinase (AMPK), which plays a role in protecting tumor cells from metabolic stresses.
NDRG2
overexpression strongly reduced glucose deprivation-induced AMPK phosphorylation and increased the cleavage of poly (ADP-ribose) polymerase (
PARP
), which indicated the induction of apoptosis. The expression of a constitutively active form of AMPK effectively blocked glucose deprivation-induced apoptosis in
NDRG2
-overexpressing MDA-MB-231 cells. Moreover,
NDRG2
overexpression also enhanced the pro-apoptotic effects of 2-deoxyglucose (2-DG) or hypoxia, an inducer of metabolic stresses. Finally, we showed that LKB1 is an upstream kinase of AMPK that is involved in the inhibition of glucose deprivation-induced AMPK activity in
NDRG2
-overexpressing cells. Our findings collectively suggest that
NDRG2
is a negative regulator of AMPK activity and functions as a sensitizer of glucose deprivation.
...
PMID:NDRG2 overexpression enhances glucose deprivation-mediated apoptosis in breast cancer cells via inhibition of the LKB1-AMPK pathway. 2506 1
The function of the stress-responsive
N-myc downstream-regulated gene 2
(
NDRG2
) in the control of myoblast growth, and the amino acids contributing to its function, are not well characterized. Here, we investigated the effect of increased
NDRG2
levels on the proliferation, differentiation and apoptosis in skeletal muscle cells under basal and stress conditions.
NDRG2
overexpression increased C2C12 myoblast proliferation and the expression of positive cell cycle regulators, cdk2, cyclin B and cyclin D, and phosphorylation of Rb, while the serine/threonine-deficient
NDRG2
, 3A-
NDRG2
, had less effect. The onset of differentiation was enhanced by
NDRG2
as determined through the myogenic regulatory factor expression profiles and myocyte fusion index. However, the overall level of differentiation in myotubes was not different. While
NDRG2
up-regulated caspase 3/7 activities during differentiation, no increase in apoptosis was measured by TUNEL assay or through cleavage of caspase 3 and
PARP
proteins. During H2O2 treatment to induce oxidative stress,
NDRG2
helped protect against the loss of proliferation and ER stress as measured by GRP78 expression with 3A-
NDRG2
displaying less protection.
NDRG2
also attenuated apoptosis by reducing cleavage of
PARP
and caspase 3 and expression of pro-apoptotic Bax while enhancing the pro-survival Bcl-2 and Bcl-xL levels. In contrast, Mcl-1 was not altered, and
NDRG2
did not protect against palmitate-induced lipotoxicity. Our findings show that
NDRG2
overexpression increases myoblast proliferation and caspase 3/7 activities without increasing overall differentiation. Furthermore,
NDRG2
attenuates H2O2-induced oxidative stress and specific serine and threonine amino acid residues appear to contribute to its function in muscle cells.
...
PMID:NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. 2638 Aug 11